Estimate Recalculated Nov 1, 2024 11:31AM EST
Helen Louise Collins has an estimated net worth of $6.41 Million. This is based on reported shares across multiple companies, which include Kura Oncology, Inc., Enliven Therapeutics, Inc., FIVE PRIME THERAPEUTICS, INC., and IO Biotech, Inc..
Helen Louise Collins's CIK is 0001701247
2020 was Helen Louise Collins's most active year for acquiring shares with 6 total transactions. Helen Louise Collins's most active month to acquire stocks was the month of January. 2021 was Helen Louise Collins's most active year for disposing of shares, totalling 11 transactions. Helen Louise Collins's most active month to dispose stocks was the month of January. 2024 saw Helen Louise Collins paying a total of $49,600.00 for 276,642 shares, this is the most they've acquired in one year. In 2021 Helen Louise Collins cashed out on 519,534 shares for a total of $5,345,569.19, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!